The receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 105 (3) , 300-306
- https://doi.org/10.1016/0304-3940(89)90637-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The amine-depleting effects of 5,7-dihydroxytryptamine (5,7-DHT) in C57BL/6 mice do not increase with ageBrain Research, 1989
- The response of striatal neuropeptide Y and cholinergic neurons to excitatory amino acid agonistsBrain Research, 1988
- Orally administered MDMA causes a long-term depletion of serotonin in rat brainBrain Research, 1988
- Dextromethorphan and dextrorphan as calcium channel antagonistsBrain Research, 1988
- Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damageTrends in Neurosciences, 1988
- Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acidsEuropean Journal of Pharmacology, 1985
- Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptorsBrain Research Reviews, 1984
- The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartateBritish Journal of Pharmacology, 1983
- Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)Journal of Pharmaceutical Sciences, 1980
- Lesion of striatal neurons with kainic acid provides a model for Huntington's choreaNature, 1976